Projects per year
Fingerprint
- 1 Similar Profiles
Collaborations and top research areas from the last five years
-
Mayo Clinic Ovarian Cancer SPORE
Kaufmann, S. H., Bell, D. A., Bible, K. C., Cliby, W. A., Couch, F. J., Fields, A. P., Galanis, E., Goode, E. L., Haluska, P. R. J., Hartmann, L. C., Karnitz, L. M., Keeney, G., Knutson, K. L., Lengyel, E., Lingle, W. L., Long, H. J., Sherman, M. E., Moriarity, B. S., Block, M. S., Oberg, A. L., Peng, K., Shridhar, V. & Weroha, S.
9/1/09 → 8/31/24
Project: Research project
-
Phase I trial of intravenous vesicular stomatitis virus for treatment of metastatic endometrial cancer
Bakkum-Gamez, J. N., Block, M. S. & Peng, K.
5/4/17 → 4/30/18
Project: Research project
-
Phase 2: NIS proteins with altered anion specificity
Suksanpaisan, L., Peng, K. & Russell, S. J.
5/1/17 → 3/31/20
Project: Research project
-
Optimizing Measles Virotherapy in the Treatment of Recurrent Ovarian Cancer
7/1/09 → 8/31/14
Project: Research project
-
Optimizing Measles Virotherapy in the Treatment of Ovarian Cancer
6/1/09 → 12/31/14
Project: Research project
-
Oncolytic α-herpesvirus and myeloid-tropic cytomegalovirus cooperatively enhance systemic antitumor responses
Jiang, H., Nace, R., Ariail, E., Ma, Y., McGlinch, E., Ferguson, C., Fernandez Carrasco, T., Packiriswamy, N., Zhang, L., Peng, K. W. & Russell, S. J., Jan 3 2024, In: Molecular Therapy. 32, 1, p. 241-256 16 p.Research output: Contribution to journal › Article › peer-review
Open Access -
A phase I oncolytic virus trial with vesicular stomatitis virus expressing human interferon beta and tyrosinase related protein 1 administered intratumorally and intravenously in uveal melanoma: safety, efficacy, and T cell responses
Smith, K. E. R., Peng, K. W., Pulido, J. S., Weisbrod, A. J., Strand, C. A., Allred, J. B., Newsom, A. N., Zhang, L., Packiriswamy, N., Kottke, T., Tonne, J. M., Moore, M., Montane, H. N., Kottschade, L. A., McWilliams, R. R., Dudek, A. Z., Yan, Y., Dimou, A., Markovic, S. N., Federspiel, M. J., & 3 others , 2023, In: Frontiers in immunology. 14, 1279387.Research output: Contribution to journal › Article › peer-review
Open Access -
Boosting of SARS-CoV-2 immunity in nonhuman primates using an oral rhabdoviral vaccine
Peng, K. W., Carey, T., Lech, P., Vandergaast, R., Muñoz-Alía, M., Packiriswamy, N., Gnanadurai, C., Krotova, K., Tesfay, M., Ziegler, C., Haselton, M., Sevola, K., Lathrum, C., Reiter, S., Narjari, R., Balakrishnan, B., Suksanpaisan, L., Sakuma, T., Recker, J., Zhang, L., & 10 others , Apr 1 2022, In: Vaccine. 40, 15, p. 2342-2351 10 p.Research output: Contribution to journal › Article › peer-review
Open Access -
Clinical activity of single-dose systemic oncolytic VSV virotherapy in patients with relapsed refractory T-cell lymphoma
Cook, J., Peng, K. W., Witzig, T. E., Broski, S. M., Villasboas, J. C., Paludo, J., Patnaik, M., Rajkumar, V., Dispenzieri, A., Leung, N., Buadi, F., Bennani, N., Ansell, S. M., Zhang, L., Packiriswamy, N., Balakrishnan, B., Brunton, B., Giers, M., Ginos, B., Dueck, A. C., & 22 others , Jun 14 2022, In: Blood Advances. 6, 11, p. 3268-3279 12 p.Research output: Contribution to journal › Article › peer-review
Open Access -
Preclinical safety assessment of MV-s-NAP, a novel oncolytic measles virus strain armed with an H. pylori immunostimulatory bacterial transgene
Viker, K. B., Steele, M. B., Iankov, I. D., Concilio, S. C., Ammayappan, A., Bolon, B., Jenks, N. J., Goetz, M. P., Panagioti, E., Federspiel, M. J., Liu, M. C., Peng, K. W. & Galanis, E., Sep 8 2022, In: Molecular Therapy Methods and Clinical Development. 26, p. 532-546 15 p.Research output: Contribution to journal › Article › peer-review
Open Access